Hit enter to search or ESC to close
Sigrid Therapeutics
  • About Us
    • Our Story
    • The Team
    • Board of Directors
    • Advisory Board
  • R&D
    • SiPore®
    • Clinical Trials
    • Prediabetes
    • Pipeline
    • Posters & Publications
  • Resources
    • Logo
  • News
    • Media
    • Blog (English)
    • Blogs (Swedish)
    • Photos
  • Contact Us
  • Consumer Prelaunch Program
  • White paper
Sigrid Therapeutics
News

Scientific study suggests that mesoporous silica particles (MSPs) interact with the lipid digestion and absorption pathways to reduce calorific uptake

Stockholm, March 21st, 2022: Sigrid Therapeutics today announced the publication of a multifaceted, scientific study…
Sana
SanaMarch 21, 2022
News

Sigrid Therapeutics granted European patent covering the use of porous SiPore® silica particles as pharmaceutical or dietary active ingredients

Stockholm, Sweden March 7, 2022. Sigrid Therapeutics, a Swedish healthtech company specializing in the prevention…
Sana
SanaMarch 7, 2022
News

Sigrid Therapeutics’ Co-founder & CEO Sana Alajmovic named Sweden’s Female Founder of the Year 2021

Sana
SanaNovember 30, 2021
News

Sigrid Therapeutics tar in 72 Mkr i nytt kapital

Kapitalet kommer från amerikanska, irländska och svenska investerare för att finansiera klinisk studie och internationell…
Sana
SanaNovember 10, 2021
News

Sigrid Therapeutics raises funding of $8.4M

This financing round was raised from US, Irish and Swedish investors alongside a large-scale industrial…
Sana
SanaNovember 10, 2021
News

Unique Swedish concept for two of the world’s biggest health challenges closer to breakthrough

Swedish Sigrid Therapeutics, which has developed a unique concept to prevent two of the world's…
Sana
SanaNovember 8, 2021
News

Sigrid Profiled in SvD, Sweden’s Largest Daily Magazine

We are happy to have been profiled in SvD, Sweden's largest daily magazine. Read more…
Sana
SanaNovember 3, 2021
News

Hjälp, utan regulatorisk rådgivning famlar vi i mörkret!

MedTech Magazine
Sana
SanaDecember 9, 2020
News

Former President of Eli Lilly Research Labs and Head of R&D Dr. Jan Lundberg invests in Sigrid Therapeutics and joins the Company’s Scientific Advisory Board

Breakthrough SiPore15TM silica particle-based diabetes and obesity treatment on track for commercial material scale up…
Liu Ming
Liu MingJune 2, 2020
News

Sana Alajmovic: ”Vi måste tala om de stora visionerna – bygga nästa Astra”

Life Science Sweden  
Ben
BenMay 12, 2020
« Previous Entries
Next Entries »

© 2023 Sigrid Therapeutics.

    • About Us
      • Our Story
      • The Team
      • Board of Directors
      • Advisory Board
    • R&D
      • SiPore®
      • Clinical Trials
      • Prediabetes
      • Pipeline
      • Posters & Publications
    • Resources
      • Logo
    • News
      • Media
      • Blog (English)
      • Blogs (Swedish)
      • Photos
    • Contact Us
    • Consumer Prelaunch Program
    • White paper